U.S. Court Dismisses Arm's Final Claim Against Qualcomm, Affirms Nuvia Licensing Compliance

Qualcomm (QCOM) secured a decisive legal victory as a U.S. District Court judge dismissed Arm Ltd.'s final claim, confirming neither Qualcomm nor its subsidiary Nuvia violated licensing agreements related to Nuvia's architecture. This ruling, which upheld a prior unanimous jury verdict and denied Arm's request for a new trial, validates Qualcomm's position on properly licensed CPU cores developed with Nuvia technology, removing a significant legal overhang. However, Qualcomm's separate lawsuit against Arm, alleging breach of contract and interference, remains active with a trial expected in March 2026.

Analysis

Qualcomm Inc. (QCOM) has secured a decisive legal victory with the U.S. District Court for the District of Delaware dismissing the final claim in a lawsuit brought by Arm Ltd. This ruling, which upholds a unanimous jury verdict from December 2024 and denies Arm's request for a new trial, effectively resolves a significant legal overhang for Qualcomm. The court's decision confirms that Qualcomm's use of technology from its subsidiary Nuvia for CPU core development falls under its existing architecture license with Arm, validating a key part of its product and innovation strategy. While this specific case is now closed in Qualcomm's favor, the broader legal dispute persists. A separate lawsuit initiated by Qualcomm against Arm, alleging breach of contract and anti-competitive behavior, remains active, with a trial anticipated in March 2026. This ongoing litigation continues to represent a source of potential risk and uncertainty for Arm's business model and its relationships with major partners.

Key Decisions for Investors

• Investors should view this ruling as a significant de-risking event for Qualcomm, as it validates the company's Nuvia acquisition and clears the path for its high-performance custom CPU roadmap, strengthening its competitive positioning.
• For Arm, this legal defeat represents a material setback, potentially weakening its control over how its architecture is used by licensees and exposing it to further legal and financial risk from Qualcomm's ongoing countersuit.
• The primary focus should now shift to Qualcomm's separate lawsuit against Arm, set for trial in March 2026, as its outcome could have more profound implications for Arm's licensing model and the competitive landscape for semiconductor IP.